Hotaling Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.21M Sell
3,309
-54
-2% -$19.1K 0.55% 61
2022
Q3
$1.09M Buy
3,363
+16
+0.5% +$5.07K 0.52% 62
2022
Q2
$1.08M Buy
3,347
+18
+0.5% +$5.4K 0.47% 67
2022
Q1
$953K Buy
3,329
+201
+6% +$51.7K 0.37% 79
2021
Q4
$864K Buy
3,128
+242
+8% +$61.3K 0.3% 76
2021
Q3
$667K Sell
2,886
-5
-0.2% -$1.23K 0.28% 77
2021
Q2
$664K Sell
2,891
-9
-0.3% -$1.81K 0.27% 79
2021
Q1
$542K Buy
2,900
+2
+0.1% +$391 0.24% 80
2020
Q4
$489K Buy
2,898
+313
+12% +$46.7K 0.23% 75
2020
Q3
$383K Buy
2,585
+51
+2% +$7.89K 0.21% 79
2020
Q2
$416K Buy
2,534
+67
+3% +$10.3K 0.24% 80
2020
Q1
$342K Buy
+2,467
New +$339K 0.25% 76

Other funds holding LLY

Hotaling Investment Management's LLY Position: Q4 2022 in Review

Hotaling Investment Management reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2022, selling an estimated $19.1K and leaving 3,309 shares worth $1.21M. The position accounts for 0.55% of the portfolio, ranked #61.

Hotaling Investment Management first reported a position in LLY in Q1 2020 and has held it in 12 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Hotaling Investment Management held 3,309 shares of Eli Lilly worth $1.21M as of Q4 2022.
  • Hotaling Investment Management sold 54 Eli Lilly shares in Q4 2022, an estimated $19.1K.
  • Eli Lilly made up 0.55% of Hotaling Investment Management's portfolio in Q4 2022, its #61 holding.
  • Hotaling Investment Management first reported a position in Eli Lilly in Q1 2020 and has held it in 12 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.